• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

当前对细胞外基质重塑与肠道通透性在健康和疾病中的相互作用的理解。

Current understanding of the interplay between extracellular matrix remodelling and gut permeability in health and disease.

作者信息

Vilardi Aurora, Przyborski Stefan, Mobbs Claire, Rufini Alessandro, Tufarelli Cristina

机构信息

Cancer Research Centre, University of Leicester, Leicester, LE2 7LX, United Kingdom.

Department of Biosciences, Durham University, Durham, DH1 3LE, United Kingdom.

出版信息

Cell Death Discov. 2024 May 27;10(1):258. doi: 10.1038/s41420-024-02015-1.

DOI:10.1038/s41420-024-02015-1
PMID:38802341
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11130177/
Abstract

The intestinal wall represents an interactive network regulated by the intestinal epithelium, extracellular matrix (ECM) and mesenchymal compartment. Under healthy physiological conditions, the epithelium undergoes constant renewal and forms an integral and selective barrier. Following damage, the healthy epithelium is restored via a series of signalling pathways that result in remodelling of the scaffolding tissue through finely-regulated proteolysis of the ECM by proteases such as matrix metalloproteinases (MMPs). However, chronic inflammation of the gastrointestinal tract, as occurs in Inflammatory Bowel Disease (IBD), is associated with prolonged disruption of the epithelial barrier and persistent damage to the intestinal mucosa. Increased barrier permeability exhibits distinctive signatures of inflammatory, immunological and ECM components, accompanied by increased ECM proteolytic activity. This narrative review aims to bring together the current knowledge of the interplay between gut barrier, immune and ECM features in health and disease, discussing the role of barrier permeability as a discriminant between homoeostasis and IBD.

摘要

肠壁是一个由肠上皮、细胞外基质(ECM)和间充质区室调节的交互网络。在健康的生理条件下,上皮细胞不断更新,形成一个完整且具有选择性的屏障。受损后,健康的上皮细胞通过一系列信号通路得以恢复,这些信号通路通过基质金属蛋白酶(MMPs)等蛋白酶对ECM进行精细调节的蛋白水解作用,从而导致支架组织重塑。然而,如炎症性肠病(IBD)中发生的胃肠道慢性炎症,与上皮屏障的长期破坏和肠黏膜的持续损伤有关。屏障通透性增加表现出炎症、免疫和ECM成分的独特特征,同时伴随着ECM蛋白水解活性的增加。这篇叙述性综述旨在汇集目前关于健康和疾病状态下肠道屏障、免疫和ECM特征之间相互作用的知识,讨论屏障通透性作为区分体内平衡和IBD的判别因素的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c20/11130177/5b7ff2643c73/41420_2024_2015_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c20/11130177/177dbaebd1cf/41420_2024_2015_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c20/11130177/371a8063c7fc/41420_2024_2015_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c20/11130177/08a169985381/41420_2024_2015_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c20/11130177/9e96db840888/41420_2024_2015_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c20/11130177/5b7ff2643c73/41420_2024_2015_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c20/11130177/177dbaebd1cf/41420_2024_2015_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c20/11130177/371a8063c7fc/41420_2024_2015_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c20/11130177/08a169985381/41420_2024_2015_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c20/11130177/9e96db840888/41420_2024_2015_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c20/11130177/5b7ff2643c73/41420_2024_2015_Fig5_HTML.jpg

相似文献

1
Current understanding of the interplay between extracellular matrix remodelling and gut permeability in health and disease.当前对细胞外基质重塑与肠道通透性在健康和疾病中的相互作用的理解。
Cell Death Discov. 2024 May 27;10(1):258. doi: 10.1038/s41420-024-02015-1.
2
Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.用于研究正常和炎症状态下人结肠上皮细胞代谢与免疫功能的体外模型的开发、验证及应用
Dan Med J. 2015 Jan;62(1):B4973.
3
Inflammatory Bowel Disease-Associated Gut Commensals Degrade Components of the Extracellular Matrix.炎症性肠病相关肠道共生菌降解细胞外基质成分。
mBio. 2022 Dec 20;13(6):e0220122. doi: 10.1128/mbio.02201-22. Epub 2022 Nov 29.
4
The Role of Extracellular Matrix Components in Inflammatory Bowel Diseases.细胞外基质成分在炎症性肠病中的作用
J Clin Med. 2021 Mar 8;10(5):1122. doi: 10.3390/jcm10051122.
5
Role of the epithelial barrier in intestinal fibrosis associated with inflammatory bowel disease: relevance of the epithelial-to mesenchymal transition.上皮屏障在炎症性肠病相关肠道纤维化中的作用:上皮-间质转化的相关性
Front Cell Dev Biol. 2023 Sep 26;11:1258843. doi: 10.3389/fcell.2023.1258843. eCollection 2023.
6
The intestinal tissue homeostasis - the role of extracellular matrix remodeling in inflammatory bowel disease.肠组织稳态 - 细胞外基质重塑在炎症性肠病中的作用。
Expert Rev Gastroenterol Hepatol. 2019 Oct;13(10):977-993. doi: 10.1080/17474124.2019.1673729. Epub 2019 Oct 22.
7
Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.下一代基质金属蛋白酶抑制剂——新策略带来新前景。
Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11 Pt A):1927-1939. doi: 10.1016/j.bbamcr.2017.06.009. Epub 2017 Jun 19.
8
Mend Your Fences: The Epithelial Barrier and its Relationship With Mucosal Immunity in Inflammatory Bowel Disease.修复屏障:炎症性肠病中的上皮屏障及其与黏膜免疫的关系
Cell Mol Gastroenterol Hepatol. 2017 Mar 23;4(1):33-46. doi: 10.1016/j.jcmgh.2017.03.007. eCollection 2017 Jul.
9
Metalloproteinases in Inflammatory Bowel Diseases.炎症性肠病中的金属蛋白酶
J Inflamm Res. 2021 Mar 23;14:1029-1041. doi: 10.2147/JIR.S288280. eCollection 2021.
10
Matrix metalloproteinases in inflammatory bowel disease: boon or a bane?炎症性肠病中的基质金属蛋白酶:是福还是祸?
Inflamm Bowel Dis. 2007 Jan;13(1):97-107. doi: 10.1002/ibd.20011.

引用本文的文献

1
Matrix remodeling-associated protein 5 as a novel biomarker for predicting disease activity and endoscopic response to infliximab in Crohn's disease.基质重塑相关蛋白5作为预测克罗恩病疾病活动度及英夫利昔单抗内镜反应的新型生物标志物
J Transl Autoimmun. 2025 Jul 7;11:100300. doi: 10.1016/j.jtauto.2025.100300. eCollection 2025 Dec.
2
Proteomic profiling of dysbiosis-challenged broilers reveals potential blood biomarkers for intestinal health.对受菌群失调挑战的肉鸡进行蛋白质组学分析,揭示了肠道健康的潜在血液生物标志物。
Vet Res. 2025 Jul 8;56(1):143. doi: 10.1186/s13567-025-01570-4.
3
Matrix Dynamics and Microbiome Crosstalk: Matrix Metalloproteinases as Key Players in Disease and Therapy.

本文引用的文献

1
Matrix metalloproteinases as biomarkers and therapeutic targets in colitis-associated cancer.基质金属蛋白酶作为结肠炎相关癌症的生物标志物和治疗靶点。
Front Oncol. 2024 Jan 15;13:1325095. doi: 10.3389/fonc.2023.1325095. eCollection 2023.
2
Matrix metalloproteinase 7 contributes to intestinal barrier dysfunction by degrading tight junction protein Claudin-7.基质金属蛋白酶 7 通过降解紧密连接蛋白 Claudin-7 导致肠道屏障功能障碍。
Front Immunol. 2022 Oct 4;13:1020902. doi: 10.3389/fimmu.2022.1020902. eCollection 2022.
3
Circulating Profile of ECM-Related Proteins as Diagnostic Markers in Inflammatory Bowel Diseases.
基质动力学与微生物组相互作用:基质金属蛋白酶在疾病与治疗中的关键作用
Int J Mol Sci. 2025 Apr 11;26(8):3621. doi: 10.3390/ijms26083621.
4
Anti-Inflammatory Effect of Dietary Pentadecanoic Fatty Acid Supplementation on Inflammatory Bowel Disease in SAMP1/YitFc Mice.膳食十五烷酸补充对 SAMP1/YitFc 小鼠炎症性肠病的抗炎作用。
Nutrients. 2024 Sep 8;16(17):3031. doi: 10.3390/nu16173031.
5
Focal Adhesion Kinase and Colony Stimulating Factors: Intestinal Homeostasis and Innate Immunity Crosstalk.黏着斑激酶和集落刺激因子:肠道稳态和固有免疫的相互作用。
Cells. 2024 Jul 11;13(14):1178. doi: 10.3390/cells13141178.
炎症性肠病中作为诊断标志物的细胞外基质相关蛋白的循环特征
J Clin Med. 2022 Sep 23;11(19):5618. doi: 10.3390/jcm11195618.
4
How to place the duality of specific MMP-9 inhibition for treatment of inflammatory bowel diseases into clinical opportunities?如何将特异性 MMP-9 抑制的双重性转化为治疗炎症性肠病的临床机会?
Front Immunol. 2022 Sep 9;13:983964. doi: 10.3389/fimmu.2022.983964. eCollection 2022.
5
Fibroblasts in intestinal homeostasis, damage, and repair.肠道稳态、损伤和修复中的成纤维细胞。
Front Immunol. 2022 Aug 10;13:924866. doi: 10.3389/fimmu.2022.924866. eCollection 2022.
6
The Role of Paracellular Transport in the Intestinal Absorption and Biopharmaceutical Characterization of Minoxidil.细胞旁路转运在米诺地尔肠道吸收及生物药剂学特征中的作用
Pharmaceutics. 2022 Jun 27;14(7):1360. doi: 10.3390/pharmaceutics14071360.
7
Intestinal Uptake and Tolerance to Food Antigens.肠道对食物抗原的摄取和耐受。
Front Immunol. 2022 Jun 10;13:906122. doi: 10.3389/fimmu.2022.906122. eCollection 2022.
8
Extracellular matrix dynamics: tracking in biological systems and their implications.细胞外基质动力学:生物系统中的追踪及其意义
J Biol Eng. 2022 May 30;16(1):13. doi: 10.1186/s13036-022-00292-x.
9
Protease-Activated Receptors - Key Regulators of Inflammatory Bowel Diseases Progression.蛋白酶激活受体——炎症性肠病进展的关键调节因子。
J Inflamm Res. 2021 Dec 29;14:7487-7497. doi: 10.2147/JIR.S335502. eCollection 2021.
10
The interplay of fibroblasts, the extracellular matrix, and inflammation in scar formation.成纤维细胞、细胞外基质和炎症在瘢痕形成中的相互作用。
J Biol Chem. 2022 Feb;298(2):101530. doi: 10.1016/j.jbc.2021.101530. Epub 2021 Dec 23.